KIM AUSTIN D. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Oct 6, 2023
Insider Transaction Report
Form 4
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2023-10-05+36,174→ 62,226 total - Exercise/Conversion
Restricted Stock Units
2023-10-05−36,174→ 60,289 total→ Common Stock (36,174 underlying) - Sale
Common Stock
2023-10-06$21.96/sh−16,369$359,463→ 45,857 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]Includes 539 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on May 15, 2023.
- [F3]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F4]Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.